Search research articles
Contact Us
Filters
Showing results (51-60 of 65) with videos related to
Page
of 7
Sort By:
The Journal of Clinical Psychiatry
|
November 7, 2014
Six-month outcomes from a randomized trial augmenting serotonin reuptake inhibitors with exposure and response prevention or risperidone in adults with obsessive-compulsive disorder
Edna B Foa, Helen Blair Simpson, David Rosenfield, et al.
JAMA Psychiatry
|
September 13, 2013
Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial
Helen Blair Simpson, Edna B Foa, Michael R Liebowitz, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
May 4, 2026
Pre-analytical guidelines for blood and CSF Biomarkers 2025: Recommendations from the NACC ADRC Biofluid Biomarker Best Practices Workgroup
Timothy E Van Meter, Edward N Wilson, Fanny Elahi, et al.
Journal of Neurotrauma
|
January 20, 2025
Prospective Harmonization, Common Data Elements, and Sharing Strategies for Multicenter Pre-Clinical Traumatic Brain Injury Research in the Translational Outcomes Project in Neurotrauma Consortium
Ina-Beate Wanner, Joseph T McCabe, J Russell Huie, et al.
Molecular Psychiatry
|
January 16, 2024
Age of onset of obsessive-compulsive disorder differentially affects white matter microstructure
Chris Vriend, Niels T de Joode, Petra J W Pouwels, et al.
JAMA Psychiatry
|
January 26, 2022
Maintenance of Wellness in Patients With Obsessive-Compulsive Disorder Who Discontinue Medication After Exposure/Response Prevention Augmentation: A Randomized Clinical Trial
Edna B Foa, Helen Blair Simpson, Thea Gallagher, et al.
Behaviour Research and Therapy
|
June 5, 2021
Maximizing remission from cognitive-behavioral therapy in medicated adults with obsessive-compulsive disorder
Helen B Simpson, Edna B Foa, Michael G Wheaton, et al.
Cancer Cell
|
July 10, 2019
A C19MC-LIN28A-MYCN Oncogenic Circuit Driven by Hijacked Super-enhancers Is a Distinct Therapeutic Vulnerability in ETMRs: A Lethal Brain Tumor
Patrick Sin-Chan, Iqra Mumal, Tannu Suwal, et al.
The Lancet. Oncology
|
April 18, 2015
Molecular subgroups of atypical teratoid rhabdoid tumours in children: an integrated genomic and clinicopathological analysis
Jonathon Torchia, Daniel Picard, Lucie Lafay-Cousin, et al.
Acta Neuropathologica
|
November 1, 2013
TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma
Marc Remke, Vijay Ramaswamy, John Peacock, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 65) with videos related to
Sort By:
Page
of 7
The Journal of Clinical Psychiatry
|
November 7, 2014
Six-month outcomes from a randomized trial augmenting serotonin reuptake inhibitors with exposure and response prevention or risperidone in adults with obsessive-compulsive disorder
Edna B Foa, Helen Blair Simpson, David Rosenfield, et al.
JAMA Psychiatry
|
September 13, 2013
Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial
Helen Blair Simpson, Edna B Foa, Michael R Liebowitz, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
May 4, 2026
Pre-analytical guidelines for blood and CSF Biomarkers 2025: Recommendations from the NACC ADRC Biofluid Biomarker Best Practices Workgroup
Timothy E Van Meter, Edward N Wilson, Fanny Elahi, et al.
Journal of Neurotrauma
|
January 20, 2025
Prospective Harmonization, Common Data Elements, and Sharing Strategies for Multicenter Pre-Clinical Traumatic Brain Injury Research in the Translational Outcomes Project in Neurotrauma Consortium
Ina-Beate Wanner, Joseph T McCabe, J Russell Huie, et al.
Molecular Psychiatry
|
January 16, 2024
Age of onset of obsessive-compulsive disorder differentially affects white matter microstructure
Chris Vriend, Niels T de Joode, Petra J W Pouwels, et al.
JAMA Psychiatry
|
January 26, 2022
Maintenance of Wellness in Patients With Obsessive-Compulsive Disorder Who Discontinue Medication After Exposure/Response Prevention Augmentation: A Randomized Clinical Trial
Edna B Foa, Helen Blair Simpson, Thea Gallagher, et al.
Behaviour Research and Therapy
|
June 5, 2021
Maximizing remission from cognitive-behavioral therapy in medicated adults with obsessive-compulsive disorder
Helen B Simpson, Edna B Foa, Michael G Wheaton, et al.
Cancer Cell
|
July 10, 2019
A C19MC-LIN28A-MYCN Oncogenic Circuit Driven by Hijacked Super-enhancers Is a Distinct Therapeutic Vulnerability in ETMRs: A Lethal Brain Tumor
Patrick Sin-Chan, Iqra Mumal, Tannu Suwal, et al.
The Lancet. Oncology
|
April 18, 2015
Molecular subgroups of atypical teratoid rhabdoid tumours in children: an integrated genomic and clinicopathological analysis
Jonathon Torchia, Daniel Picard, Lucie Lafay-Cousin, et al.
Acta Neuropathologica
|
November 1, 2013
TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma
Marc Remke, Vijay Ramaswamy, John Peacock, et al.
Page
of 7